Announcement of the 15 medicines chosen for the second round of negotiations was one of the Biden administration’s final ...

The Centers for Medicare & Medicaid Services (CMS) said Friday that it had selected another 15 drugs for its second round of ...

FF/VI was administered once daily via the Ellipta inhaler. Patients who were taking a LAMA in addition to ICS/LABA therapy (triple therapy) who were randomised to the FF/VI group were able to ...

The drugs picked for negotiations this year also include Trelegy Ellipta, a prescription inhaler for chronic obstructive pulmonary disease and asthma; and Xtandi, Pomalyst, Ibrance and Calquence ...

Trelegy Ellipta, an inhaler used for asthma and chronic obstructive sleep apnea, is included, as are Otezla, a psoriasis medicine, and Vraylar, an antipsychotic. Ozempic and Wegovy are ...

The parents of a young Wisconsin man have sued Walgreens and pharmacy benefit manager OptumRx over their son’s death from an ...

Relvar Ellipta is a once-daily dual combination treatment comprising fluticasone furoate, an inhaled corticosteroid and vilanterol, a long-acting beta2-agonist, in a single inhaler, the Ellipta.

The two blockbusters Novo Nordisk medicines are among 15 additional drugs whose prices Medicare will be allowed to negotiate ...

It launched Trelegy Ellipta, the countrys first single inhaler triple therapy (SITT) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) patients. It launched Augmentin ...

Inhaler colors often are used to identify specific types of ... Combination medications that include triple therapy drugs (ICS-LAMA-LABA, like Breztri or Trelegy Ellipta). This group also includes ...